Log In
person
TriSalus Life Sciences Inc
TLSI
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Drug Delivery Infusion Systems |
Implantable Drug Delivery Pump Systems
These companies manufacture devices that are implanted in the body and deliver a drug to the patient.
|
18.51M | 100.00% |
| Drug Delivery Infusion Systems |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Drug Delivery Infusion Systems
Implantable Drug Delivery Pump Systems
|
18.51M | 100.00% |
| keyboard_arrow_right |
These companies manufacture devices that are implanted in the body and deliver a drug to the patient.
|
||
| keyboard_arrow_down |
Drug Delivery Infusion Systems
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||